AIP1's Role in Eye Blood Vessel Growth
Author Information
Author(s): Li Yonghao, Sun Yimeng, Xie Dasen, Chen Hui, Zhang Qi, Zhang Shaochong, Wen Feng, Ou Jing‐Song, Zhang Min, Su Lishi, Li Xuri, Wen Wei‐Ping, Chi Wei
Primary Institution: Shenzhen Eye Hospital, Shenzhen Key Laboratory of Ophthalmology, Jinan University
Hypothesis
AIP1 may regulate inflammatory angiogenesis and VEGF signaling in the early stage of the disease.
Conclusion
AIP1 inhibits pathological angiogenesis by preventing endothelial pyroptosis, revealing potential therapeutic targets for ocular diseases.
Supporting Evidence
- AIP1 was identified as a key anti-angiogenic factor in retinal vascular endothelial cells.
- AIP1 inhibits VEGF signaling and prevents endothelial pyroptosis.
- Downregulation of AIP1 was observed in retinal VECs of OIR mice.
- Genetic deletion of AIP1 led to increased neovascularization in a murine model.
- AIP1 overexpression reduced hypoxia-induced tube formation in HUVECs.
- The NLRP12-CASP8 inflammasome was found to promote VEGF signaling and angiogenesis.
- GSDMD-mediated pyroptosis was linked to increased VEGFA release.
Takeaway
AIP1 is like a superhero for eye blood vessels, stopping them from growing too much when they shouldn't, which helps prevent vision loss.
Methodology
The study used single-cell RNA sequencing and murine models to investigate the role of AIP1 in retinal vascular endothelial cells under hypoxic conditions.
Potential Biases
Potential bias in the interpretation of results due to reliance on specific animal models.
Limitations
The study primarily focuses on murine models, which may not fully replicate human ocular conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website